Activity | Visit 1 | Visit 2 | Visit 3 | Visit 4 | Visit 5 | Visit 6 | Visit 7 | Visit 8 |
---|---|---|---|---|---|---|---|---|
Time Schedule | Week 1 | Baseline | Week 2 | Week 4 | Week 6 | Week 8 | Week 12 | Week 16 |
Window visit |  | ±3 days | ±3 days | ±3 days | ±3 days | ±3 days | ±3 days | ±3 days |
Demographic information-taking | X | Â | Â | Â | Â | Â | Â | Â |
Informed consent form | X | Â | Â | Â | Â | Â | Â | Â |
General medical history-taking | X | Â | Â | Â | Â | Â | Â | Â |
Photographing the patient’s face Count of inflammatory/non-inflammatory lesions | X | X | X | X | X | X |  |  |
Blood tests (liver function test, renal function test) | X | Â | Â | Â | Â | X | Â | Â |
Blood tests | Â | X | Â | Â | Â | X | Â | Â |
Urine pregnancy test | X | Â | Â | Â | Â | X | Â | Â |
Randomization & allocation | Â | X | Â | Â | Â | Â | Â | Â |
Investigational Produce | Â | X | X | X | X | Â | Â | Â |
Numeric rating scale (menstrual pain) | Â | X | Â | X | Â | X | X | X |
Verbal multidemensional scoring system grade | X | X | Â | X | Â | X | X | X |
Investigator’s Static Global Assessment Scale of Facial Acne Vulgaris |  | X | X | X | X | X |  |  |
Numeric rating scale (acne) | Â | X | X | X | X | X | X | X |
Monitoring adverse events | Â | Â | X | X | X | X | X | X |
Compliance check | Â | Â | X | X | X | X | Â | Â |
Blinding check | Â | Â | Â | Â | Â | X | Â | Â |